Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX2ZXO
|
||||
Drug Name |
4-(2-{4-[(2-Amino-4-hydroxy-quinazolin-6-ylmethyl)-ethynyl-amino]-benzoylamino}-4-carboxy-butyrylamino)-4-carboxy-butyric acid anion
|
||||
Synonyms |
CHEMBL1160189
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C28H28N6O9
|
||||
Canonical SMILES |
Nc1nc(O)c2cc(CN(C#C)c3ccc(cc3)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)O)C(=O)O)ccc2n1
|
||||
InChI |
InChI=1S/C28H28N6O9/c1-2-34(14-15-3-8-19-18(13-15)25(40)33-28(29)32-19)17-6-4-16(5-7-17)24(39)30-20(9-11-22(35)36)26(41)31-21(27(42)43)10-12-23(37)38/h1,3-8,13,20-21H,9-12,14H2,(H,30,39)(H,31,41)(H,35,36)(H,37,38)(H,42,43)(H3,29,32,33,40)
|
||||
InChIKey |
CUZJGZKZBQUBIR-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Dihydrofolate reductase | Target Info | [1587926] | ||
Thymidylate synthase | Target Info | [1587926] | |||
BioCyc Pathway | Pyrimidine deoxyribonucleotides biosynthesis from CTP | ||||
Pyrimidine deoxyribonucleotides de novo biosynthesis | |||||
Superpathway of pyrimidine deoxyribonucleotides de novo biosynthesis | |||||
Superpathway of pyrimidine deoxyribonucleoside salvage | |||||
DTMP de novo biosynthesis (mitochondrial) | |||||
Pyrimidine deoxyribonucleosides salvage | |||||
Pathway Interaction Database | E2F transcription factor network | ||||
PathWhiz Pathway | Folate Metabolism | ||||
Pterine BiosynthesisPW000160:Pyrimidine Metabolism | |||||
WikiPathways | Trans-sulfuration and one carbon metabolism | ||||
Retinoblastoma (RB) in Cancer | |||||
One Carbon Metabolism | |||||
Integrated Pancreatic Cancer Pathway | |||||
miR-targeted genes in muscle cell - TarBase | |||||
miR-targeted genes in lymphocytes - TarBase | |||||
miR-targeted genes in leukocytes - TarBase | |||||
miR-targeted genes in epithelium - TarBase | |||||
Metabolism of nucleotides | |||||
Fluoropyrimidine Activity | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.